文献速递主动脉疾病

二氧化碳自动注射系统在血管腔内主动脉瘤修复术中的标准化

Standardization of a Carbon Dioxide Automated System for Endovascular Aortic Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2018-03-06

2016年8月至10月连续31例标准EVAR患者接受标准化CO₂注射(100 mL、300 mm Hg,经11 cm 10F股动脉鞘,自动注射装置),以常规对比剂为金标准评估CO₂ DSA对近端和远端锚定区的显示及内漏检出。CO₂ DSA识别近端锚定区19/31(61%)、远端31/31(100%),完成期CO₂ DSA检出II型内漏10例 vs 常规对比剂2例。

要点

  • CO₂ DSA可识别远端锚定区31/31(100%),近端锚定区仅19/31(61%)。
  • 12例(39%)CO₂未能显示至少最低肾动脉,见于瘤腔大、附壁血栓少、管腔容积大于95.9(IQR 25.2)mm³的动脉瘤。
  • 完成期CO₂ DSA检出II型内漏10例,常规对比剂检出2例。

核心结论

  • 经自动装置注射无毒CO₂在多数病例中可有效完成EVAR操作。
  • 部分病例单次注射最小量常规对比剂可弥补CO₂对肾动脉显示不足。
  • CO₂较标准对比剂更常显示II型内漏;CO₂注射技术尤其在肾动脉检测方面需进一步改进,但该技术有前景并可能替代标准对比剂,对肾功能有显著益处。

研究设计与样本

  • 2016年8月至10月连续纳入31例接受标准EVAR的患者,中位年龄76.1岁(IQR 7.4)。
  • 经11 cm 10F股动脉鞘,用专门制造的自动注射装置(Angiodroid Srl, San Lazzaro, Bologna, Italy)以300 mm Hg注射100 mL CO₂识别近端和远端锚定区。
  • EVAR释放前用常规对比剂行确认性注射;以同过程中常规对比剂注射为金标准,评估CO₂ DSA精确显示近端和远端锚定区的可能性。
  • 术终用两种技术评估内漏存在情况。

主要发现

  • CO₂ DSA识别移植物近端肾旁锚定区19/31例(61%),远端锚定区31/31例(100%)。
  • 12例(39%)CO₂注射未能显示至少最低肾动脉,发生在瘤体大、血栓贴附少且管腔容积大于95.9(IQR 25.2)mm³的动脉瘤。
  • 完成期CO₂ DSA检出II型内漏10例,常规对比剂检出2例。

临床怎么用

  • 作者认为,经自动装置注射无毒CO₂在多数病例中可有效完成EVAR操作。
  • 作者认为,部分病例可单次注射最小量常规对比剂以弥补CO₂对肾动脉显示不足。
  • 作者指出,CO₂注射技术尤其在肾动脉检测方面需进一步改进,但该技术有前景并可能替代标准对比剂,对肾功能有显著益处。

局限性

  • 原文在结论中指出CO₂注射技术尤其在肾动脉检测方面需进一步改进。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aortic repair (EVAR) is presently the preferred treatment for abdominal aortic aneurysm; however, it requires the injection of a contrast medium, which can hamper the renal function. Other nontoxic agents such as carbon dioxide (CO2) have been sporadically tested in this setting with uncertain results. The aim of the study is to investigate the efficacy of a new standardized CO2 injection method in standard EVAR procedures. METHODS: Between August and October 2016, 31 consecutive patients (median age 76.1 [interquartile range {IQR}: 7.4] years) were submitted to standard EVAR. Proximal and distal endograft landing zones were identified by the injection of 100 mL of CO2 at 300 mm Hg, through an 11 cm 10F femoral sheath by a specifically manufactured automated injection device (Angiodroid Srl, San Lazzaro, Bologna, Italy). Before EVAR deployment, a confirmative injection with a conventional contrast medium was accomplished. The possibility of precisely visualizing the proximal and distal landing zones by CO2 digital subtraction angiography (DSA) was evaluated considering the contrast medium injection obtained in the same procedure as a gold standard. Similarly, the possible presence of endoleak was assessed at the end of the procedure by the 2 techniques. RESULTS: CO2 DSA allowed to identify the juxtarenal landing zone of the endograft in 19/31 cases (61%) and the distal one in 31/31 (100%). In 12 (39%) cases, CO2 injection failed to visualize at least the lowest renal artery. This occurred in large aneurysms with scarce thrombotic apposition and a luminal volume greater than 95.9 (IQR: 25.2) mm3. Completion CO2 DSA detected type II endoleaks (ELIIs) in 10 cases compared with 2 of conventional contrast media. CONCLUSIONS: The injection of nontoxic CO2 through an automated device allowed to perform EVAR procedures effectively, in the majority of cases. In some cases, a single injection of a minimum amount of conventional contrast medium can be used to overcome the lack of renal artery visualization by CO2. ELIIs are more frequently visualized with CO2 compared with standard contrast medium. Although the CO2 injection technique needs further amelioration particularly in the renal arteries detection, this technique appears promising and possibly substitutive of the standard contrast medium, with significant benefit for the renal function.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mascoli C, Faggioli G, Gallitto E, et al. Standardization of a Carbon Dioxide Automated System for Endovascular Aortic Aneurysm Repair. Ann Vasc Surg. 2018. PMID: 29522871. doi:10.1016/j.avsg.2018.01.099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。